FIORF logo

Fiore Cannabis Ltd. (FIORF) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

FIORF representa a Fiore Cannabis Ltd., una empresa del sector Healthcare con un precio de $ (capitalización de mercado 0). La acción obtiene una puntuación de 55/100, una calificación moderada basada en 9 KPI cuantitativos.

Ultimo analisis: 17 mar 2026
Puntuación de IA de 55/100

Fiore Cannabis Ltd. (FIORF) Resumen de Asistencia Médica y Tuberías

CEOErik Anderson
Sede CentralKelowna, CA
Año de la oferta pública inicial (OPI)2015

Fiore Cannabis Ltd. operates in the U.S. cannabis market, focusing on cultivation, production, and distribution of medical and recreational marijuana. The company also runs a dispensary in California, integrating both upstream and downstream operations within a competitive and evolving regulatory landscape.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 17 mar 2026

Tesis de Inversión

Fiore Cannabis Ltd. presents a speculative investment opportunity within the evolving U.S. cannabis market. The company's vertical integration, encompassing cultivation, production, and retail through its California dispensary, offers potential for margin capture across the value chain. However, the company's negative profit margin of -280.9% indicates significant operational challenges. Key catalysts include potential regulatory changes in the U.S. that could expand market access. Investors should closely monitor the company's ability to improve profitability and manage its operations effectively. The company's beta of 0.83 suggests lower volatility compared to the overall market. The absence of a dividend reflects its focus on reinvesting earnings for growth. The market capitalization of $0.00B indicates that it is a micro-cap stock.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Operates in the U.S. medical and recreational cannabis market.
  • Vertically integrated with cultivation, production, and retail operations.
  • Gross margin of 22.6% indicates potential for profitability improvements.
  • Negative profit margin of -280.9% reflects current operational challenges.
  • Beta of 0.83 suggests lower volatility compared to the market.

Competidores y Pares

Fortalezas

  • Vertically integrated operations.
  • Dispensary in California.
  • Focus on both medical and recreational markets.

Debilidades

  • Negative profit margin.
  • Limited geographic presence.
  • Small market capitalization.

Catalizadores

  • Upcoming: Potential changes in U.S. federal cannabis regulations could expand market access and reduce regulatory burdens.
  • Ongoing: Expansion of operations into new states as cannabis legalization progresses.
  • Ongoing: Development and launch of new cannabis-infused products to meet evolving consumer demand.
  • Ongoing: Strategic partnerships and acquisitions to enhance capabilities and market reach.

Riesgos

  • Ongoing: Intense competition in the cannabis industry could pressure margins and limit market share.
  • Potential: Fluctuations in cannabis prices could impact revenue and profitability.
  • Potential: Changes in state and local regulations could create compliance challenges and increase costs.
  • Potential: Limited access to capital could constrain growth opportunities.
  • Ongoing: Negative profit margin indicates operational inefficiencies.

Oportunidades de crecimiento

  • Expansion into New Markets: Fiore Cannabis can explore opportunities to expand its operations into additional states as cannabis legalization progresses across the U.S. This includes states with established medical cannabis programs and those considering recreational legalization. Entering new markets would require navigating different regulatory frameworks and establishing local partnerships. The U.S. cannabis market is projected to reach $40 billion by 2030, offering significant growth potential for companies that can successfully expand their geographic footprint. Timeline: Ongoing.
  • Product Innovation and Development: Fiore Cannabis can invest in research and development to create new and innovative cannabis products, such as edibles, concentrates, and topicals. This includes developing products with specific cannabinoid profiles and formulations to target different consumer needs and preferences. The market for cannabis-infused products is growing rapidly, driven by increasing consumer interest in alternative consumption methods. By developing differentiated products, Fiore Cannabis can enhance its brand reputation and attract new customers. Timeline: Ongoing.
  • Strategic Partnerships and Acquisitions: Fiore Cannabis can pursue strategic partnerships and acquisitions to expand its capabilities and market reach. This includes partnering with other cannabis companies, technology providers, and distribution networks. Acquisitions can provide access to new markets, technologies, and product lines. Strategic partnerships can help Fiore Cannabis leverage the expertise and resources of other companies to accelerate its growth. Timeline: Ongoing.
  • Optimization of Cultivation and Production Processes: Fiore Cannabis can focus on optimizing its cultivation and production processes to improve efficiency and reduce costs. This includes implementing advanced cultivation techniques, such as hydroponics and vertical farming, to maximize yields and minimize resource consumption. By improving its operational efficiency, Fiore Cannabis can enhance its profitability and competitiveness. Timeline: Ongoing.
  • Enhancement of Retail Operations: Fiore Cannabis can enhance its retail operations by improving the customer experience and expanding its product offerings. This includes creating a welcoming and informative retail environment, providing personalized customer service, and offering a wide range of cannabis products and accessories. By enhancing its retail operations, Fiore Cannabis can attract and retain customers, increase sales, and build brand loyalty. Timeline: Ongoing.

Oportunidades

  • Expansion into new states.
  • Development of new cannabis products.
  • Strategic partnerships and acquisitions.

Amenazas

  • Changing regulations.
  • Intense competition.
  • Fluctuations in cannabis prices.

Ventajas competitivas

  • Vertical integration provides control over the supply chain.
  • Dispensary operations provide direct access to consumers.
  • Brand recognition in the California market.

Acerca de FIORF

Fiore Cannabis Ltd., formerly known as Citation Growth Corp., rebranded in October 2020 to reflect its focus on the cannabis industry. Incorporated in 2007 and headquartered in Kelowna, Canada, the company cultivates, produces, and distributes medical and recreational marijuana in the United States. Fiore Cannabis operates a dispensary in California, allowing it to directly serve consumers. The company's operations span the entire value chain, from cultivation to retail, positioning it as a vertically integrated player in the cannabis market. Fiore Cannabis aims to capitalize on the growing demand for cannabis products in the U.S., navigating the complex regulatory environment to establish a strong market presence. The company's strategy involves optimizing its cultivation and production processes to ensure high-quality products and efficient operations. By focusing on both medical and recreational markets, Fiore Cannabis seeks to diversify its revenue streams and cater to a broad customer base.

Qué hacen

  • Cultivates medical marijuana.
  • Cultivates recreational marijuana.
  • Produces medical marijuana products.
  • Produces recreational marijuana products.
  • Distributes medical marijuana products.
  • Distributes recreational marijuana products.
  • Operates a dispensary in California.

Modelo de Negocio

  • Cultivation and production of cannabis.
  • Distribution of cannabis products to dispensaries.
  • Retail sales through its own dispensary.

Contexto de la Industria

Fiore Cannabis Ltd. operates within the rapidly expanding U.S. cannabis industry. The market is characterized by increasing legalization, evolving regulations, and growing consumer demand for both medical and recreational cannabis products. The industry is highly competitive, with numerous players vying for market share. Key trends include the consolidation of smaller companies, the development of new cannabis-infused products, and the increasing focus on quality and branding. Fiore Cannabis competes with other cannabis producers and retailers, including CBGI, HCANF, LOWLF, MDIT, and MDXL, all of whom are navigating similar regulatory and market dynamics.

Clientes Clave

  • Medical marijuana patients in the U.S.
  • Recreational cannabis users in the U.S.
  • Dispensaries in California.
Confianza de la IA: 69% Actualizado: 17 mar 2026

Finanzas

Gráfico e información

Precio de la acción de Fiore Cannabis Ltd. (FIORF): Price data unavailable

Últimas noticias

No hay noticias recientes disponibles para FIORF.

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para FIORF.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para FIORF.

MoonshotScore

55/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de FIORF en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Liderazgo: Erik Anderson

CEO

Erik Anderson serves as the CEO of Fiore Cannabis Ltd. His background includes experience in the cannabis industry, with a focus on operations and business development. He has been involved in various aspects of the cannabis value chain, from cultivation to retail. Anderson's expertise lies in navigating the complex regulatory landscape and building sustainable business models in the cannabis sector. He is committed to driving growth and innovation at Fiore Cannabis.

Historial: Under Erik Anderson's leadership, Fiore Cannabis Ltd. has focused on expanding its operations in the U.S. cannabis market. Key milestones include the rebranding of the company and the optimization of its cultivation and production processes. Anderson has also overseen the development of new cannabis products and the enhancement of the company's retail operations. His strategic decisions have aimed at improving the company's profitability and competitiveness.

Información del mercado OTC de FIORF

The OTC Other tier, also known as the Pink Sheets, represents the lowest tier of the over-the-counter (OTC) market. Companies listed on this tier typically do not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB, or major exchanges like NYSE or NASDAQ. This tier is often populated by speculative or distressed companies, and may include companies with limited operating history or those that are thinly traded. Investing in companies on the OTC Other tier carries significant risks due to the lack of regulatory oversight and transparency.

  • Nivel OTC: OTC Other
  • Estado de divulgación: Unknown
Liquidez: Liquidity for FIORF on the OTC market is likely to be limited. As an OTC Other stock, it may experience low trading volume and wide bid-ask spreads, making it difficult to buy or sell shares at desired prices. This lack of liquidity can increase the risk of price volatility and make it challenging to exit a position quickly. Investors should be aware of these liquidity constraints when considering an investment in FIORF.
Factores de riesgo OTC:
  • Limited financial disclosure.
  • Low trading volume and liquidity.
  • Potential for price manipulation.
  • Lack of regulatory oversight.
  • Speculative nature of the business.
Lista de verificación de diligencia debida:
  • Verify the company's legal standing and registration.
  • Review available financial statements and disclosures.
  • Assess the company's business model and competitive position.
  • Evaluate the management team's experience and track record.
  • Understand the regulatory environment and potential risks.
  • Monitor trading volume and price volatility.
  • Consult with a financial advisor.
Señales de legitimidad:
  • Operation of a dispensary in California.
  • Focus on both medical and recreational markets.
  • Rebranding efforts to focus on the cannabis industry.

FIORF Preguntas Frecuentes sobre Acciones de Healthcare

¿Cuáles son los factores clave para evaluar FIORF?

Fiore Cannabis Ltd. (FIORF) actualmente tiene una puntuación IA de 55/100, indicando puntuación moderada. Fortaleza clave: Vertically integrated operations.. Riesgo principal a monitorear: Ongoing: Intense competition in the cannabis industry could pressure margins and limit market share.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de FIORF?

FIORF actualmente puntúa 55/100 (Grado C) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de FIORF?

Los precios de FIORF se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre FIORF?

La cobertura de analistas para FIORF incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en FIORF?

Las categorías de riesgo para FIORF incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Ongoing: Intense competition in the cannabis industry could pressure margins and limit market share.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de FIORF?

La relación P/E para FIORF compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está FIORF sobrevalorada o infravalorada?

Determinar si Fiore Cannabis Ltd. (FIORF) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de FIORF?

Fiore Cannabis Ltd. (FIORF) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • Financial data is limited due to the company's OTC listing.
  • Analyst coverage is unavailable.
  • The cannabis industry is subject to rapid regulatory changes.
Fuentes de datos

Popular Stocks